Three isolates of zygomycetes were used to produce a disseminated infection in nonimmunocompromised mice. Against all zygomycete strains, amphotericin B significantly prolonged survival. Itraconazole was inactive against Rhizopus microsporus and Rhizopus oryzae but was partially active against Absidia corymbifera. Posaconazole had no beneficial effects against R. oryzae but showed partial activity against A. corymbifera. Posaconazole had a clear dose-response effect against R. microsporus
AbstractTo date, no reference standard for therapy for zygomycosis has been established because ther...
We used two established neutropenic murine models of pulmonary aspergillosis and mucormycosis to exp...
We evaluated and compared the efficacies of different antifungal drugs against Sarocladium kiliense ...
Three isolates of zygomycetes were used to produce a disseminated infection in nonimmunocompromised ...
A broth microdilution method was used to evaluate the in vitro activities of seven antifungal agents...
Three isolates of zygomycetes belonging to three different genera (Rhizopus microsporus, Absidia cor...
We evaluated the activities of amphotericin B, itraconazole, voriconazole, caspofungin, and posacona...
Objectives: We evaluated the in vitro activity of posaconazole and amphotericin B against several cl...
AbstractThe treatment of zygomycosis has two cornerstones, namely, surgery and antifungal drugs. In ...
Objectives: We have compared the efficacy of posaconazole and amphotericin B in an experimental muri...
International audienceWe have determined the in vitro activity of amphotericin B (AMB) and posaconaz...
The new antifungal derivative posaconazole was tested against three clinical isolates of Cryptococcu...
In vitro susceptibilities of 36 zygomycete isolates, belonging to six genera, to itraconazole, posac...
In vitro susceptibilities of 36 zygomycete isolates, belonging to six genera, to itraconazole, posac...
We assessed prophylactic or continuous therapy of isavuconazole, posaconazole, or voriconazole in tr...
AbstractTo date, no reference standard for therapy for zygomycosis has been established because ther...
We used two established neutropenic murine models of pulmonary aspergillosis and mucormycosis to exp...
We evaluated and compared the efficacies of different antifungal drugs against Sarocladium kiliense ...
Three isolates of zygomycetes were used to produce a disseminated infection in nonimmunocompromised ...
A broth microdilution method was used to evaluate the in vitro activities of seven antifungal agents...
Three isolates of zygomycetes belonging to three different genera (Rhizopus microsporus, Absidia cor...
We evaluated the activities of amphotericin B, itraconazole, voriconazole, caspofungin, and posacona...
Objectives: We evaluated the in vitro activity of posaconazole and amphotericin B against several cl...
AbstractThe treatment of zygomycosis has two cornerstones, namely, surgery and antifungal drugs. In ...
Objectives: We have compared the efficacy of posaconazole and amphotericin B in an experimental muri...
International audienceWe have determined the in vitro activity of amphotericin B (AMB) and posaconaz...
The new antifungal derivative posaconazole was tested against three clinical isolates of Cryptococcu...
In vitro susceptibilities of 36 zygomycete isolates, belonging to six genera, to itraconazole, posac...
In vitro susceptibilities of 36 zygomycete isolates, belonging to six genera, to itraconazole, posac...
We assessed prophylactic or continuous therapy of isavuconazole, posaconazole, or voriconazole in tr...
AbstractTo date, no reference standard for therapy for zygomycosis has been established because ther...
We used two established neutropenic murine models of pulmonary aspergillosis and mucormycosis to exp...
We evaluated and compared the efficacies of different antifungal drugs against Sarocladium kiliense ...